Literature DB >> 19218258

HIV prevention and psychoactive drug use: a research agenda.

D C Des Jarlais1, S Semaan.   

Abstract

Much has been learned about how to prevent HIV infection among psychoactive drug users in the last 25 years, but, worldwide, the problems of drug-use-related HIV transmission have increased during this time. We consider the need for additional research on four aspects of drug use-related HIV transmission: (1) why evidence-based effective prevention programmes have not been implemented, (2) HIV infection among ethnic minority drug users, (3) relationships--or lack of relationships--between individual risk behaviour and HIV infection and (4) reducing drug use-related sexual transmission of HIV and other sexually transmitted infections (STIs). These topics were selected because we see them as critical for reducing HIV transmission among drug users (topics 1 and 4), reducing health disparities among racial and ethnic groups of drug users (topic 2), and understanding HIV epidemiology and evaluating prevention programmes for drug users (topic 3).

Entities:  

Mesh:

Year:  2009        PMID: 19218258     DOI: 10.1136/jech.2008.079301

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  5 in total

1.  Ethical considerations in surveys employing respondent-driven sampling.

Authors:  Salaam Semaan; Douglas D Heckathorn; Don C Des Jarlais; Richard S Garfein
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

Review 2.  Prevention of HIV infection among injection drug users in resource-limited settings.

Authors:  David Vlahov; Angela M Robertson; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

3.  Individual and neighborhood correlates of membership in drug using networks with a higher prevalence of HIV in New York City (2006-2009).

Authors:  Abby E Rudolph; Natalie D Crawford; Carl Latkin; James H Fowler; Crystal M Fuller
Journal:  Ann Epidemiol       Date:  2013-03-21       Impact factor: 3.797

Review 4.  HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Salaam Semaan; Evan Wood
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

5.  Social and individual risk determinants of HIV testing practices among noninjection drug users at high risk for HIV/AIDS.

Authors:  Kellee White; Abby E Rudolph; Kandice C Jones; Carl Latkin; Ebele O Benjamin; Natalie D Crawford; Crystal M Fuller
Journal:  AIDS Care       Date:  2012-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.